NINA GARDNER: Open Payments
NPI 1124801006 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 66 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,157 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 38 | $565 |
| Madrigal Pharmaceuticals | 4 | $419 |
| Gilead Sciences, Inc. | 10 | $328 |
| Ipsen Biopharmaceuticals, Inc | 5 | $163 |
| Mirum Pharmaceuticals, Inc. | 2 | $85 |
| ORPHALAN INC | 3 | $75 |
| Mallinckrodt Hospital Products Inc. | 2 | $56 |
| ABBVIE INC. | 1 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: XIFAXAN, REZDIFFRA, IQIRVO, Livdelzi, Livmarli, CUVRIOR, TERLIVAZ, LINZESS.
Industry payments across NY — which companies pay providers there.
